With nearly 65,000 open studies listed on ClinicalTrials.gov exploring topics from AIDS to Zika, the arrival of better clinical care over time can feel inevitable. Yet, with most trials geared toward showing whether a therapy or device is safe and effective on its own and less so how it stacks up to other options, critical gaps in medical knowledge often remain. Which current treatments work best and for which patients is often unknown. Read More
A new report from health communications company Ogilvy Healthworld released last week revealed a high level of social media activity by the top 20 pharmaceutical companies, but argues that pharma's social media strategy could use some tweaking. Read More
The biopharma sector is heading into the final quarter with plenty of work to do to salvage some respectability from what has so far proved to be a turbulent and challenging year. With one more trading day before the books close on the third quarter, we took a quick look at where the industry stands prior to our deeper analysis on its business and financial performance in next week's issue. Read More
